Redx Pharma Limited

Redx is a clinical-stage biotechnology company focused on the discovery and development of small molecule, targeted medicines for the treatment of fibrotic disease, cancer, and cancer-associated fibrosis. The company has experience in drug discovery and has delivered multiple molecules to clinical stage development.
  • Zelasudil (RXC007, ROCK2 selective)
  • RXC008 (GI-targeted pan-ROCK inhibitor)
  • Zamaporvint (RXC004, Porcupine Inhibitor)
  • Oncology and fibrosis research programmes
Size
Medium
Phone
N/A
Website
redxpharma.com
Email
N/A
Locations
Alderley Park, Block 33 Mereside, SK10 4TG
01625469900
9:00 - 18:00
Digital Popularity
Popularity over time
Social Media
Company Details
Redx Pharma Limited is operated by Redx Pharma Limited and is a Active company incorporated on 7 September 2010 with the registered office located in Macclesfield, Cheshire. Redx Pharma Limited was registered 15 years ago.
Status
Active
Size
Small
Directors
7
Age
15 years old
Employees
74
Turnover
£13.52M
Total Assets
£28.36M
Cash in Bank
£18.56M
Total Liabilities
-£21.08M
Lisa Mary Whewell Anson
Director • Pharmaceuticals Executive • British • Lives in England • Born in Apr 1968
Jeremy Charles Green
Director • Portfolio Manager • British • Lives in France • Born in Jun 1973
Claire Catherinet
Director • Senior Associate At Sofinnova Partners • French • Lives in France • Born in Sep 1990
Peter Eric Presland
Director • Chartered Accountant • British • Lives in England • Born in Apr 1950
Natalie Berner
Director • Co Director • American • Lives in United States • Born in Dec 1990
Dr Bernhard Jurgen Kirschbaum
Director • German • Lives in Germany • Born in May 1958
More information on Redx Pharma Limited
Teams
All
65
Research
41
Management
28
Marketing
2
Customer Service
1
Other
10
Inder Bhamra
Vice President Drug Discovery • Joined Nov 2022
Nicolas Guisot
Vice President, Drug Discovery • Joined Nov 2022
Helen McKeever
Vice President Head Of Nonclinical Development • Joined Sep 2024
Cliff Jones
Senior Vice President Chemistry, DMPK & IP • Joined Nov 2022
Lisa LM Anson
Chief Executive Officer • Joined Jun 2018
Kay Eckersley
Principal Scientist • Joined Aug 2015
Kirsty Houslay
Principal Scientist • Joined Dec 2023
Joe Lewis-Marshall
Principal Scientist • Joined Sep 2021
Amy Marshall
Principal Scientist • Joined Jul 2024
Helen Aylott
Associate Principal Scientist • Joined Jan 2024
Kay Eckersley
Principal Scientist • Joined Aug 2015
Kirsty Houslay
Principal Scientist • Joined Dec 2023
Joe Lewis-Marshall
Principal Scientist • Joined Sep 2021
Amy Marshall
Principal Scientist • Joined Jul 2024
Helen Aylott
Associate Principal Scientist • Joined Jan 2024
Paula Jackson
Associate Principal Scientist • Joined Jan 2023
Nicola Hamilton
Associate Principal Scientist • Joined Dec 2021
Christopher Piekarski
Associate Principal Scientist • Joined Dec 2021
Elaine Kilgour
Head Of Translational Science • Joined Jan 2023
Jonathan Cheung
Associate Scientist
Lisa LM Anson
Chief Executive Officer • Joined Jun 2018
Kay Eckersley
Principal Scientist • Joined Aug 2015
Kirsty Houslay
Principal Scientist • Joined Dec 2023
Joe Lewis-Marshall
Principal Scientist • Joined Sep 2021
Amy Marshall
Principal Scientist • Joined Jul 2024
James Mead
Chief Operating Officer • Joined May 2021
David Marshall
Procurement Lead • Joined Aug 2022
Hayley Thomas
HR Manager • Joined Mar 2015
Caroline Phillips
Head Of Oncology • Joined Sep 2018
Helen Timmis
Senior Medical Director • Joined Feb 2022
Caitlin Pearson
Head Of Communications • Joined Apr 2022
Caroline Phillips
Head Of Oncology • Joined Sep 2018
Alexander Haworth
IT Support Lead • Joined Mar 2021
Inder Bhamra
Vice President Drug Discovery • Joined Nov 2022
Nicolas Guisot
Vice President, Drug Discovery • Joined Nov 2022
Helen McKeever
Vice President Head Of Nonclinical Development • Joined Sep 2024
Cliff Jones
Senior Vice President Chemistry, DMPK & IP • Joined Nov 2022
James McDonagh
Principal ChemAI Scientist • Joined Jul 2024
Simon Woodcock
VP, Oncology • Joined Nov 2022
Caroline Phillips
SVP Biology • Joined Nov 2022
Cinzia Bordoni
Senior Scientist In Medicinal Chemistry And Expert In Computational Chemistry • Joined Jul 2022
Joanne Kelley
Business Development Redx Pharma • Joined Sep 2019
Alex H
Strategic Finance / Corp Dev • Joined Sep 2024
View 65 members